A Phase I/II Trial of Concurrent Chemohormonal Therapy Using Enzalutamide (MDV-3100) and Cabazitaxel in Patients With Metastatic Castration Resistant Prostate Cancer
Phase of Trial: Phase I/II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Enzalutamide (Primary) ; Cabazitaxel
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Jan 2018 Planned primary completion date changed from 30 Jun 2018 to 31 Jan 2019.
- 12 Jul 2017 Planned primary completion date changed from 1 Jun 2018 to 30 Jun 2018.
- 10 Jun 2017 Biomarkers information updated